TRNS

+ Watchlist + Portfolio

Transcat, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $91.77
52-Week Range: $50.23 – $100.00
Market Cap: $856.52M
P/E (TTM): 254.19
EPS (TTM): 0.36
Dividend Yield: —

Advanced Metrics

Price/Book: 2.84
PEG Ratio: —
Return on Equity: 1.16%
Return on Assets: 2.18%
Gross Margin: 32.50%
Operating Margin: 5.47%
Profit Margin: 0.99%
Current Ratio: 2.49
Debt/Equity: 0.47
Total Debt: $143.25M
Free Cash Flow: $27.98M
Revenue Growth: 21.60%
Earnings Growth: -60.00%
Enterprise Value: $995.49M

TRNS Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$230.57M	$259.48M	$278.42M	$331.88M
Cost of Revenue	$162.21M	$175.68M	$188.97M	$223.57M
Gross Profit	$68.36M	$83.81M	$89.45M	$108.30M
Selling, General & Admin	$52.11M	$64.03M	$71.58M	$95.04M
Operating Expenses	$52.11M	$64.03M	$71.58M	$95.04M
Operating Income	$16.25M	$19.78M	$17.87M	$13.26M
EBITDA	$26.86M	$33.82M	$37.69M	$38.76M
Pretax Income	$13.49M	$18.44M	$18.33M	$7.99M
Income Tax	$2.80M	$4.79M	$3.81M	$2.61M
Net Income	$10.69M	$13.65M	$14.52M	$5.38M
Diluted EPS	1.40	1.63	1.57	0.57
Diluted Shares	7.64M	8.35M	9.25M	9.38M

TRNS Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$1.53M	$19.65M	$1.52M	$4.94M
Receivables	$45.20M	$48.28M	$56.31M	$65.84M
Inventory	$16.93M	$17.42M	$14.48M	$13.71M
Current Assets	$67.60M	$105.16M	$78.01M	$92.46M
Total Assets	$195.75M	$287.55M	$385.24M	$480.49M
Current Liabilities	$28.32M	$33.50M	$34.04M	$39.63M
Long-Term Debt	$46.87M	$1.82M	$30.89M	$99.89M
Total Debt	$64.41M	$21.54M	$57.73M	$133.26M
Total Liabilities	$96.12M	$62.38M	$98.36M	$179.87M
Retained Earnings	$69.16M	$80.07M	$92.52M	$97.76M
Shareholders' Equity	$99.63M	$225.17M	$286.88M	$300.62M
Working Capital	$39.28M	$71.66M	$43.97M	$52.83M
Net Debt	$47.59M	—	$31.19M	$94.94M

TRNS Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$16.95M	$32.62M	$38.98M	$34.85M
Capital Expenditure	-$9.41M	-$13.28M	-$13.20M	-$15.30M
Free Cash Flow	$7.54M	$19.34M	$25.79M	$19.55M
Depreciation & Amortisation	$10.96M	$13.54M	$18.57M	$26.17M
Stock-Based Compensation	$3.38M	$4.51M	$3.25M	$7.55M
Investing Cash Flow	-$18.51M	-$41.67M	-$84.00M	-$97.82M
Financing Cash Flow	$876.00K	$27.40M	$26.86M	$66.50M
Share Repurchases	-$447.00K	-$4.91M	-$3.56M	-$469.00K
Net Change in Cash	-$686.00K	$18.34M	-$18.15M	$3.53M

TRNS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$77.13M	$76.42M	$82.27M	$83.86M	$89.33M
Cost of Revenue	$51.22M	$50.60M	$55.51M	$58.60M	$58.86M
Gross Profit	$25.91M	$25.82M	$26.76M	$25.25M	$30.47M
Selling, General & Admin	$18.97M	$20.48M	$23.26M	$25.16M	$26.14M
Operating Expenses	$18.97M	$20.48M	$23.26M	$25.16M	$26.14M
Operating Income	$6.94M	$5.34M	$3.50M	$88.00K	$4.33M
EBITDA	$12.35M	$10.62M	$9.79M	$7.19M	$11.16M
Pretax Income	$6.26M	$4.57M	$2.03M	-$1.44M	$2.83M
Income Tax	$1.79M	$1.30M	$760.00K	-$338.00K	$887.00K
Net Income	$4.46M	$3.26M	$1.27M	-$1.10M	$1.95M
Diluted EPS	0.48	0.35	0.14	-0.12	0.21
Diluted Shares	9.29M	9.39M	9.40M	9.33M	9.40M

TRNS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$1.52M	$1.86M	$5.08M	$3.47M	$4.94M
Receivables	$56.31M	$58.36M	$63.21M	$59.79M	$65.84M
Inventory	$14.48M	$15.39M	$13.06M	$12.91M	$13.71M
Current Assets	$78.01M	$79.65M	$85.75M	$80.81M	$92.46M
Total Assets	$385.24M	$392.54M	$484.89M	$472.89M	$480.49M
Current Liabilities	$34.04M	$27.28M	$35.30M	$36.62M	$39.63M
Long-Term Debt	$30.89M	$33.18M	$111.89M	$99.89M	$99.89M
Total Debt	$57.73M	$65.72M	$147.75M	$134.00M	$133.26M
Total Liabilities	$98.36M	$100.00M	$189.47M	$176.12M	$179.87M
Retained Earnings	$92.52M	$95.79M	$96.97M	$95.84M	$97.76M
Shareholders' Equity	$286.88M	$292.54M	$295.42M	$296.77M	$300.62M
Working Capital	$43.97M	$52.37M	$50.44M	$44.19M	$52.83M
Net Debt	$31.19M	$32.54M	$106.80M	$96.41M	$94.94M

TRNS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$10.63M	$3.62M	$12.88M	$12.14M	$6.20M
Capital Expenditure	-$2.69M	-$4.60M	-$4.43M	-$2.68M	-$3.59M
Free Cash Flow	$7.93M	-$975.00K	$8.45M	$9.47M	$2.61M
Depreciation & Amortisation	$5.63M	$5.61M	$6.49M	$7.13M	$6.95M
Stock-Based Compensation	$1.17M	$1.13M	$1.84M	$2.06M	$2.52M
Investing Cash Flow	-$4.04M	-$4.60M	-$86.96M	-$2.68M	-$3.59M
Financing Cash Flow	-$9.45M	$1.95M	$77.25M	-$12.21M	-$488.00K
Share Repurchases	-$357.00K	$0.00	-$110.00K	$13.00K	-$372.00K
Net Change in Cash	-$2.85M	$971.00K	$3.17M	-$2.74M	$2.12M

Market Snapshot

About

Transcat is a leading distributor of professional-grade test, measurement, and calibration instruments and provides accredited calibration services. The company serves life sciences, pharmaceutical, biotechnology, aerospace, defense, and other highly regulated industries requiring precision measurement and compliance. Transcat operates through its Distribution and Service segments across North America.